A Systematic Review of the Economic and Health-Related Quality of Life Impact of Advanced Therapies Used to Treat Moderate-to-Severe Ulcerative Colitis

INTRODUCTION: The clinical benefits of advanced therapies (i.e., biologics and small-molecule drugs) in the treatment of moderate-to-severe ulcerative colitis (UC) have been demonstrated; however, there is less clarity regarding the economic and health-related quality of life (HRQoL) impact of these...

Descripción completa

Detalles Bibliográficos
Autores principales: Cichewicz, Allie, Tencer, Tom, Gupte-Singh, Komal, Egodage, Sonya, Burnett, Heather, Kumar, Jinender
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130125/
https://www.ncbi.nlm.nih.gov/pubmed/37000363
http://dx.doi.org/10.1007/s12325-023-02488-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130125/
https://www.ncbi.nlm.nih.gov/pubmed/37000363
http://dx.doi.org/10.1007/s12325-023-02488-z

Ejemplares similares